Oral oncolytics: part 1--financial, adherence, and management challenges

Oncology (Williston Park). 2013 Aug;27(8):742-4, 824.
No abstract available

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents* / therapeutic use
  • Disease Management
  • Humans
  • Medication Adherence*

Substances

  • Antineoplastic Agents